N/A
N=384
Post-resection Treatment of Large Colon Polyps
Recurrence
Bottom Line
View on ClinicalTrials.gov: NCT03654209 ↗Enrolled (actual)
384
Serious AEs
7.8%
Results posted
Jan 2024
Primary outcome: Primary: Recurrence — 10; 5; 24 Polyps
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Argon Plasma Coagulation (Device); Snare Tip Soft Coagulation (Device)
- Age
- Adult, Older Adult · 25+ yrs
- Sex
- All
- Sponsor
- Indiana University
- Primary completion
- Dec 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Recurrence |
10; 5; 24 | — |
| PRIMARY Types of Recurrences |
8; 5; 15; 2; 0; 8 | — |
| SECONDARY Time |
4.08; 3.35; NA | — |
| SECONDARY Complications |
3; 4; 6; 0; 0; 0 | — |
Summary
Patients who have provided informed consented and are scheduled to undergo endoscopic mucosal resection (EMR) of lesions 15mm and larger will be randomized to STSC (80 W, Effect 5) vs APC (preferred settings) vs No Treatment of the perimeter of the EMR site.
Eligibility Criteria
Inclusion Criteria
- 25 years and older
- Ability to provide informed consent
- Undergoing colonoscopy for screening, surveillance, diagnostic reasons, or removal of a lesion
Exclusion Criteria
- Pedunculated lesions
- Inflammatory bowel disease
- Inability to provide informed consent
- Lesions less than 15mm in largest dimension
Data sourced from ClinicalTrials.gov (NCT03654209). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.